无超声对应物的结构扭曲的断层合成引导真空辅助乳腺活检:一项回顾性综述
该单中心回顾性研究纳入2017年6月1日至2020年1月15日因无超声对应物的结构扭曲行数字乳腺断层合成引导真空辅助活检(DBT VAB)的142例患者共151处病变,最终恶性率为19%(29/151),其中83%为浸润性癌且54%为小叶亚型;作者据此认为该恶性率支持推荐使用DBT VAB进行活检。
要点
- 无超声对应物的结构扭曲行DBT VAB的最终恶性率为19%(29/151)。
- DBT VAB初始恶性27例(18%),高危病变50例(33%),良性74例(49%)。
- 恶性病变中83%(24/29)为浸润性癌,其中54%(13/24)为小叶亚型。
核心结论
- 无超声对应物的结构扭曲行DBT VAB的最终恶性率为19%,作者据此认为该结果支持推荐使用DBT VAB进行活检。
研究设计与样本
- 单中心回顾性研究,回顾2017年6月1日至2020年1月15日因无超声对应物的结构扭曲行DBT VAB的影像、病理切片和/或报告。
- 共纳入142例患者(平均年龄59岁)的151处无超声对应物的结构扭曲。
- 根据对应组织病理学将病例分为良性、高危或恶性,并汇总具体组织病理学诊断。
关键影像表现/征象
- DBT VAB结果显示恶性27处(18%)、高危病变50处(33%)、良性诊断74处(49%)。
- 2例导管非典型增生升级为恶性,最终恶性率为19%(29/151)。
- 恶性病变中大多数为浸润性癌(83%,24/29),其中大多数浸润性癌为小叶亚型(54%,13/24)。
- 高危病变中大多数为放射状瘢痕/复杂硬化性病变(62%,31/50)。
- 良性结果中大多数为纤维囊性变(66%,49/74)。
诊断标准与关键数值
- 最终恶性率定义为初始恶性加上随访升级为恶性的病例,为19%(29/151)。
- 良性结果中11%(8/74)被认为影像-病理不一致并随后切除,均无恶性。
临床应用与阅片要点
- 作者认为无超声对应物的结构扭曲19%的最终恶性率支持推荐使用DBT VAB进行活检。
- 详细的影像-病理相关性有助于放射科医生在行DBT VAB时评估结构扭曲的一致性,并为未来患者管理提供参考。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Digital breast tomosynthesis-guided vacuum-assisted breast biopsy (DBT VAB) allows biopsy of findings seen better or exclusively on digital breast tomosynthesis (DBT), including architectural distortion. Although architectural distortion with an associated sonographic mass correlate has a high risk of malignancy, limited data describe the radiologic-pathologic correlation of tomosynthesis-detected architectural distortion without a sonographic correlate. OBJECTIVE. This study evaluates the malignancy rate of architectural distortions without a sonographic correlate that undergo DBT VAB and provides radiologic-pathologic correlation for benign, high-risk, and malignant entities that are associated with architectural distortion. METHODS. We retrospectively reviewed imaging, as well as pathology slides and/or reports, for DBT VABs performed for architectural distortion without a sonographic correlate at a single institution between June 1, 2017, and January 15, 2020. According to the correlative histopathology, cases were categorized as benign, high risk, or malignant, and specific histopathologic diagnoses were summarized. RESULTS. During the study period, 142 patients (mean age, 59 years) underwent DBT VAB for 151 unique architectural distortions without a sonographic correlate. DBT VAB revealed a malignant diagnosis in 27 (18%), a high-risk lesion in 50 (33%), and a benign diagnosis in 74 (49%). Two cases of atypical ductal hyperplasia were upgraded to malignancy, resulting in a final malignancy rate of 19% (n = 29/151). Most malignant lesions were invasive carcinomas (83%, n = 24/29); most invasive carcinomas were of lobular subtype (54%, n = 13/24). Most high-risk lesions were radial scars/complex sclerosing lesions (62%, n = 31/50). Most benign results represented fibrocystic change (66%, n = 49/74). A subset (11%, n = 8/74) of benign results were considered discordant and subsequently excised, with none representing malignancy. CONCLUSION. The final malignancy rate of 19% in architectural distortion without a sonographic correlate justifies a recommendation for biopsy using DBT VAB. CLINICAL IMPACT. Our results highlight the utility of DBT VAB in the era of DBT. The detailed radiologic-pathologic correlations will assist radiologists in assessing concordance when performing DBT VAB for architectural distortions and provide a reference for future patient management.
引用
- Ambinder EB, Plotkin A, Euhus D, et al. Tomosynthesis-Guided Vacuum-Assisted Breast Biopsy of Architectural Distortion Without a Sonographic Correlate: A Retrospective Review. AJR Am J Roentgenol. 2020. PMID: 33147055. doi:10.2214/AJR.20.24740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。